Fountain Life is a technology company.
Fountain Life has raised $33.0M across 2 funding rounds.
Fountain Life has raised $33.0M in total across 2 funding rounds.
Fountain Life has raised $33.0M in total across 2 funding rounds.
Fountain Life's investors include Bold Capital Partners, Eos Venture Partners.
Fountain Life is a cutting-edge health and longevity company that provides AI-powered preventative diagnostics, personalized health optimization plans, and regenerative therapeutics to detect diseases early and extend healthspan.[1][2][3][6] Founded in 2020 and headquartered in Orlando, Florida, it serves high-net-worth individuals and wellness-focused clients through tiered memberships (CORE, APEX, EPIC), offering comprehensive services like advanced imaging, genetic testing, biomarker analysis, and 24/7 concierge care via its Zori AI platform.[2][3][4][5] The company has raised $48.89M in Series B-III funding and is expanding with new centers, such as in Houston, while identifying life-threatening conditions in 14% of seemingly healthy members through proactive screening.[2][3][5]
Fountain Life was founded in 2020 by Tony Robbins (business leader and motivational speaker), Dr. Peter Diamandis (entrepreneur and longevity advocate), Dr. Robert Hariri (stem cell pioneer), and Dr. William Kapp (CEO and serial healthcare entrepreneur with experience in surgical centers, hospitals, and EHR systems).[1][3][4] The idea emerged to address a critical gap in reactive healthcare by shifting to proactive, AI-driven prevention and healthspan extension, leveraging advancements in diagnostics, AI, and regenerative medicine.[1][3] Early traction came from integrating these technologies into a holistic model, with pivotal expansions like the Houston center in late 2024 and ongoing growth fueled by rising demand for longevity solutions.[3][5]
Fountain Life stands out in preventative healthcare through:
These elements create a vertically integrated platform that shifts healthcare from reactive treatment to predictive prevention.[1][4]
Fountain Life rides the longevity and healthspan revolution, capitalizing on AI, genomics, gene therapy, and cellular medicine to enable early disease detection and reversal of aging effects.[1][3][5] Timing is ideal amid global wellness booms—post-pandemic health awareness and predictions of decades-extended healthspans this decade—positioning it against competitors like Function Health in a market favoring proactive models over symptom-based care.[2][5] Market forces like AI advancements and rising demand for personalized medicine work in its favor, with Fountain Life influencing the ecosystem by publishing insights from its datasets, training practitioners via Fountain University, and normalizing preventative longevity for elites, potentially scaling to broader access.[4][5]
Fountain Life is poised for accelerated expansion with more centers, deeper AI enhancements in Zori, and integration of emerging longevity breakthroughs like gene therapies.[5] Trends in AI diagnostics, regenerative medicine, and global wellness will propel its growth, evolving its influence from premium memberships to potentially population-wide health optimization via data partnerships and practitioner certification.[4][5] As the company detects actionable risks in 14% of members and continues funding rounds, it could redefine healthcare standards, tying back to its mission: empowering proactive choices for longer, vital lives in an era where longevity is a choice guided by insight.[1][5][6]
Fountain Life has raised $33.0M across 2 funding rounds. Most recently, it raised $18.0M Series B in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2025 | $18.0M Series B | Bold Capital Partners, Eos Venture Partners | |
| Dec 1, 2022 | $15.0M Series A | Bold Capital Partners, Eos Venture Partners |